We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
-7.67%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$21.1B
AUM Growth
+$3.39B
(+19%)
Cap. Flow
+$5.28B
Cap. Flow
% of AUM
25.07%
Top 10 Holdings %
Top 10 Hldgs %
19.17%
Holding
1,642
New
480
Increased
535
Reduced
285
Closed
318
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AB InBev
BUD
|
+$365M |
| 2 |
Ambev
ABEV
|
+$276M |
| 3 |
Bank of America
BAC
|
+$234M |
| 4 |
Vodafone
VOD
|
+$227M |
| 5 |
Starbucks
SBUX
|
+$214M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$237M |
| 2 |
Nokia
NOK
|
+$212M |
| 3 |
Qualcomm
QCOM
|
+$189M |
| 4 |
AGN
Allergan plc
AGN
|
+$130M |
| 5 |
iShares MSCI Brazil ETF
EWZ
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.75% |
| 2 | Consumer Staples | 16.46% |
| 3 | Healthcare | 14.42% |
| 4 | Technology | 13.7% |
| 5 | Consumer Discretionary | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Lam Research
LRCX
$390B
| $9.79M | 0.05% |
+1,498,000
| New | +$11M |
|
352
Sanofi
SNY
$104B
| $9.78M | 0.05% |
+206,028
| New | +$10.5M |
|
353
L3Harris
LHX
$53.4B
| $9.71M | 0.05% |
132,700
+119,200
| +883% | +$9.32M |
|
354
Lazard
LAZ
$4.31B
| $9.5M | 0.05% |
219,416
+116,832
| +114% | +$6.02M |
|
|
POLY
355
DELISTED
Plantronics, Inc.
POLY
| $9.47M | 0.04% |
186,266
-4,038
| -2% | -$221K |
|
356
Marriott Vacations Worldwide
VAC
$4.25B
| $9.44M | 0.04% |
138,587
+99,041
| +250% | +$7.78M |
|
357
Gilead Sciences
GILD
$165B
| $9.41M | 0.04% |
+95,800
| New | +$10.6M |
|
|
BBL
358
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $9.38M | 0.04% |
305,993
-480,970
| -61% | -$16.9M |
|
359
CBRE Group
CBRE
$42.9B
| $9.3M | 0.04% |
290,745
+79,569
| +38% | +$2.82M |
|
360
OneMain Financial
OMF
$7.47B
| $9.28M | 0.04% |
212,218
+25,489
| +14% | +$1.19M |
|
|
OUTR
361
DELISTED
OUTERWALL INC
OUTR
| $9.27M | 0.04% |
162,831
+75,200
| +86% | +$5.16M |
|
362
Adtran
ADTN
$616M
| $9.22M | 0.04% |
631,414
+19,306
| +3% | +$305K |
|
363
Alaska Air
ALK
$5.58B
| $9.17M | 0.04% |
+115,400
| New | +$8.81M |
|
364
Comscore
SCOR
$109M
| $9.11M | 0.04% |
9,871
+22
| +0.2% | +$23.8K |
|
|
TYC
365
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $9.11M | 0.04% |
+260,046
| New | +$10M |
|
|
AF
366
DELISTED
Astoria Financial Corporation
AF
| $9.09M | 0.04% |
564,295
-128,758
| -19% | -$1.99M |
|
367
Aegon
AEG
$14.1B
| $9.04M | 0.04% |
2,187,128
-3,317,269
| -60% | -$16M |
|
368
Carter's
CRI
$1.47B
| $9.02M | 0.04% |
99,500
+71,400
| +254% | +$7.15M |
|
369
WaFd
WAFD
$2.75B
| $8.97M | 0.04% |
394,522
+147,772
| +60% | +$3.39M |
|
370
Campbell Soup
CPB
$6.87B
| $8.96M | 0.04% |
176,700
+26,500
| +18% | +$1.3M |
|
371
Fossil Group
FOSL
$318M
| $8.93M | 0.04% |
159,742
-30,425
| -16% | -$1.93M |
|
|
CMO
372
DELISTED
Capstead Mortgage Corp.
CMO
| $8.91M | 0.04% |
900,539
-142,633
| -14% | -$1.55M |
|
|
FITB
373
Fifth Third Bancorp
FITB
$51.8B
| $8.9M | 0.04% |
+470,894
| New | +$9.57M |
|
374
Bio-Rad Laboratories Class A
BIO
$9.42B
| $8.87M | 0.04% |
66,025
+6,615
| +11% | +$952K |
|
|
ABMD
375
DELISTED
Abiomed Inc
ABMD
| $8.85M | 0.04% |
95,400
-39,600
| -29% | -$3.49M |
|
Similar funds
VGA
Arrowstreet Capital's Q3 2015 Portfolio in Review
As of Q3 2015, Arrowstreet Capital held 1,642 positions worth $21.1B, up 19% from $17.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital deployed $5.28B of net new capital in Q3 2015, opening 480 new positions and adding to 535 existing holdings. Its largest new stake was BP: 2,515,866 shares worth $64.7M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 18% a quarter earlier, followed by Consumer Staples and Healthcare.
On the sell side, the largest reduction was Intel, an estimated $237M trimmed.
- Arrowstreet Capital's largest Q3 2015 buy was BP: 2,515,866 shares worth $64.7M.
- Arrowstreet Capital added most to AB InBev in Q3 2015, an estimated $365M increase.
- Arrowstreet Capital's biggest Q3 2015 reduction was Intel, cutting an estimated $237M.
- Arrowstreet Capital fully exited Nokia in Q3 2015, selling an estimated $212M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $21.1B portfolio in Q3 2015.
- Arrowstreet Capital opened 480 new positions and closed 318 in Q3 2015.
- Arrowstreet Capital's portfolio value rose 19% quarter-over-quarter to $21.1B.
Based on Arrowstreet Capital's 13F filing for Q3 2015, filed 5 Nov 2015.